John Marshall Bancorp, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that John Marshall Bancorp, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.23M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $17.12M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.16M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $31.80M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $25.46M | Mar 23, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.58M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $17.26M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $18.00M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $33.16M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $32.35M | Mar 23, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $554.0K | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $483.0K | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $612.0K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $156.0K | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $353.0K | Mar 23, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33B | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.23B | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.24B | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.35B | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.15B | Mar 23, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07B | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.99B | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.01B | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.14B | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.94B | Mar 23, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $265.64M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $246.61M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $229.91M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $212.80M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $208.47M | Mar 20, 2024 |
| FY2022 | Dec 31, 2020 | $186.08M | Mar 23, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.91M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $159.95M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $146.39M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $146.63M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $117.63M | Mar 23, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $129.97M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $122.47M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $99.01M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $61.60M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $105.80M | Mar 23, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.88M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $80.79M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $24.71M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $24.62M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $42.73M | Mar 23, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 2 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 23, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 2 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 23, 2023 |